This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB04726/identifier/pdb/
n9http://linked.opendata.cz/resource/drugbank/drug/DB04726/identifier/pubchem-compound/
n13http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB04726/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB04726/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04726
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB04726 n13:DB04726
dcterms:title
7,8,10-TRIMETHYLBENZO[G]PTERIDINE-2,4(3H,10H)-DIONE
adms:identifier
n9:66184 n10:46508913 n11:DB04726 n12:LFN
n3:IUPAC-Name
n4:271B4DA1-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4DA7-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4DA6-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4DA3-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4DA4-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4DA5-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4D9F-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4DA0-363D-11E5-9242-09173F13E4C5 n4:271B4D9D-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4D9E-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4DAD-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4DAE-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4DA8-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4DA9-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4DAB-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4DAA-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4DAC-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4DB3-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4DB5-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4DB6-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4DB2-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4DB1-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4DB4-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4DA2-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4DAF-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4DB0-363D-11E5-9242-09173F13E4C5